Curcumin (Diferuloylmethane Derivative) With or Without Bioperine in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Non-Myeloablative HLA-Matched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
Safety Study of IPI-504 in Patients With Relapsed and Relapsed Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1 Study of Vorinostat and Bortezomib in Multiple Myeloma (MK-0683-015 EXT 1 (AM1))
- Status
- COMPLETED
- Phase
- PHASE1
UARK 2005-01 Study of Velcade, Thalidomide, and Dexamethasone (VTD) With or Without Adriamycin® in Relapsed/Refractory Patients
- Status
- COMPLETED
- Phase
- PHASE3
VELCADE/Melphalan/Prednisone Versus Melphalan/Prednisone in Patients With Previously Untreated Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
S0340 MRI and Fludeoxyglucose F18 PET in Diagnosing Solitary Plasmacytoma
- Status
- TERMINATED
- Phase
- PHASE2
A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Multiple Myeloma (0683-004)
- Status
- TERMINATED
- Phase
- PHASE1
A Multiple Myeloma Trial in Patients With Bone Metastases
- Status
- COMPLETED
- Phase
- PHASE4
Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE3
Study of DOXIL/CAELYX (Pegylated Liposomal Doxorubicin) and VELCADE (Bortezomib) or VELCADE Monotherapy for the Treatment of Relapsed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Thalidomide Plus Dexamethasone (Thal-Dex) Versus DOXIL plusThalidomide Plus Dexamethasone (DOXIL -Thal-Dex) in Patients With Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Motexafin Gadolinium for the Treatment of Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Extension Study of the Efficacy and Safety of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Bortezomib and Revlimid™ for Patients Relapsing or Progressing on Total Therapy II
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Doxil, Vincristine and Decadron (DVd) +/ CC-5013 in Relapsed Refractory Multiple Myeloma (MM)
- Status
- COMPLETED
- Phase
- PHASE1
CC-5013 With or Without Dexamethasone in Treating Patients With Primary Systemic Amyloidosis
- Status
- COMPLETED
- Phase
- PHASE2
Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3